Next, the rationale for using Poly (I:C) as a model synthetic dsRNA was verified, as we wanted to determine if the immunostimulatory effects of Poly (I:C) would still be expressed in RAW 264.7 macrophage cells derived from murine leukemia tumors with our Lyz aggregate delivery depot system. The gene discussed is LYZ; the disease is leukemia.